The corona single dose vaccine will be available soon. Johnson & Johnson applied for emergency clearance. This vaccine works more effectively than the vaccines already available.
Vaccines have been made available in many countries around the world to control the Covid epidemic. When it comes to the existing vaccines, almost all vaccines require a second dose over a period of 28 days. Another important point is that after the second dose, provides 90 percent protection against corona. Some pharma companies are doing research on single dose vaccine. It included predictions on the Johnson & Johnson vaccine. The company has recently provided good news.
Johnson & Johnson says their single-dose vaccine works more effectively than the covid vaccines available so far. Applied to U.S. regulatory agencies seeking permission for emergency use. The vaccine will be distributed as soon as it is approved and arrangements have been made.
Johnson & Johnson said their vaccine provides 100 percent protection against covid deaths. The vaccine protects against the virus within 14 days. It is known that two vaccines have already been approved in the US. A decision on vaccine approval is likely to be made soon after reviewing the information provided by Johnson & Johnson.
Johnson & Johnson has already announced that they have developed a single-dose vaccine that is 66 percent effective in combating the corona virus. Revealed that 85 percent showed efficacy in severe cases. The single-dose vaccine has been tested on 44,000 people worldwide. The results were then revealed. The vaccine has been shown to be 72 percent effective in the United States, 66 percent in Latin America and 57 percent in South Africa.